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Central Hypothyroidism in Miniature Schnauzers
Annemarie M.W.Y. Voorbij, Peter A.J. Leegwater, Jenny J.C.W.M. Buijtels, Sylvie Daminet, and
Hans S. Kooistra
Background: Primary hypothyroidism is a common endocrinopathy in dogs. In contrast, central hypothyroidism is rare in
this species.
Objectives: The objective of this article is to describe the occurrence and clinical presentation of central hypothyroidism
in Miniature Schnauzers. Additionally, the possible role of the thyroid-stimulating hormone (TSH)-releasing hormone recep-
tor (TRHR) gene and the TSHb (TSHB) gene was investigated.
Animals: Miniature Schnauzers with proven central hypothyroidism, based on scintigraphy, and the results of a 3-day-
TSH-stimulation test, or a TSH-releasing hormone (TRH)-stimulation test or both, presented to the Department of Clinical
Sciences of Companion Animals at Utrecht University or the Department of Medicine and Clinical Biology of Small Animals
at Ghent University from 2008 to 2012.
Methods: Retrospective study. Pituitary function tests, thyroid scintigraphy, and computed tomography (CT) of the pitui-
tary area were performed. Gene fragments of aﬀected dogs and controls were ampliﬁed by polymerase chain reaction (PCR).
Subsequently, the deoxyribonucleic acid (DNA) sequences of the products were analyzed.
Results: Central hypothyroidism was diagnosed in 7 Miniature Schnauzers. Three dogs had disproportionate dwarﬁsm
and at least one of them had a combined deﬁciency of TSH and prolactin. No disease-causing mutations were found in the
TSHB gene and the exons of the TRHR gene of these Schnauzers.
Conclusions and clinical importance: Central hypothyroidism could be underdiagnosed in Miniature Schnauzers with
hypothyroidism, especially in those of normal stature. The fact that this rare disorder occurred in 7 dogs from the same breed
suggests that central hypothyroidism could have a genetic background in Miniature Schnauzers.
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Hypothyroidism is one of the most common endo-crinopathies in dogs. Defects at any level of the
hypothalamus-pituitary-thyroid axis can lead to deﬁ-
cient secretion of thyroid hormones. Hypothyroidism
can be classiﬁed as primary or central, and both forms
can be congenital or acquired. In central hypothy-
roidism, the thyroids are not aﬀected primarily but are
deprived of stimulation by thyroid-stimulating hormone
(TSH). The condition is rare compared with primary
hypothyroidism.1
Adult-onset central hypothyroidism may be because
of a tumor of the pituitary or adjacent regions,2 lym-
phocytic adenohypophysitis,3 head trauma,4 nontrau-
matic intracranial hemorrhage,5 or hypophysectomy.6
Juvenile central hypothyroidism may be because of
either isolated TSH deﬁciency or combined pituitary
hormone deﬁciency (CPHD). In dogs, the best-known
example of congenital central hypothyroidism is that of
pituitary dwarﬁsm in German Shepherd Dogs, charac-
terized by a combined deﬁciency of all adenohypophy-
seal hormones except ACTH.7 Combined pituitary
hormone deﬁciency, including TSH deﬁciency, has also
been described in a 12-week-old dog after head injury.8
Isolated TSH deﬁciency is very uncommon in dogs
being reported in a family of Giant Schnauzers,9 in a
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young Boxer,10 and in a 2-week-old Portuguese
Water Dog.11
This retrospective study describes the occurrence of
central hypothyroidism in Miniature Schnauzers and
suggests that this rare disorder may have a genetic
background in this breed.
Materials and Methods
Dogs
Medical records of Miniature Schnauzers, presented to the
Department of Clinical Sciences of Companion Animals at
Utrecht University or the Department of Medicine and Clinical
Biology of Small Animals at Ghent University from 2008 to 2012,
were evaluated for inclusion in the study. All Miniature Sch-
nauzers with proven central hypothyroidism, based on the combi-
nation of clinical signs, low plasma total thyroxine (TT4)
concentration, absent or insuﬃcient thyroid uptake of radioactive
pertechnetate (99mTcO4
) and either a plasma TSH concentration
in the lower part of the reference range that did not increase after
TRH administration or increased thyroid uptake of 99mTcO4

after 3 days of TSH stimulation combined with a rise in plasma
TT4 concentration after repeated TSH administration, were
included. Data from signalment, clinical history, physical examina-
tion, complete blood count, biochemical blood testing, hormone
determinations, diagnostic imaging, and the eﬀect of treatment
with levothyroxine were recorded.
Twenty-ﬁve Miniature Schnauzers served as control dogs for
the genetic studies. These dogs were presented with thyroid-unre-
lated illnesses, and therefore, thyroid function was not tested.
Blood samples were collected with informed consent of the dog
owners and genomic DNA (gDNA) was isolated from the samples
by a salt extraction method.12
Hormone measurements
Plasma concentrations of TT4 and TSH were evaluated by com-
mercial homologous solid-phase chemiluminescent enzyme
immunoassay activities (Immulite canine total T4, Immulite canine
TSH).a Reference intervals for plasma TT4 and TSH concentra-
tions in euthyroid dogs are 1.48–3.57 lg/dL [19–46 nmol/L] and
<0.60 ng/mL, respectively.
Plasma growth hormone (GH) concentration was measured by
a commercially available radioimmunoassay (RIA) for porcine
and canine GH, with a reference range of <5 lg/L.b Plasma insu-
lin-like growth factor-1 (IGF-1) concentration was measured by a
heterologous RIA, validated for the dog.13 Plasma prolactin con-
centration was also measured by a heterologous RIA, validated
for the dog.14 Plasma ACTH concentration was measured by a
commercially available immunoradiometric assay for humans,c val-
idated for the dog,15 with a reference interval of 5–85 pg/mL.
Plasma cortisol concentration was measured by a RIA (Coat-A-
Count Cortisol, DPC), validated for the dog,15 with a reference
interval of 0.40–4.93 lg/dL [11–136 nmoL/L].
Function tests
The thyroid glands were stimulated with 90 lg recombinant
human (rh)TSHd administered IV on 3 consecutive days. Blood
samples for the determination of plasma TT4 concentration were
collected in heparin-coated tubes immediately before and every
24 hours after rhTSH administration.1
TRH-stimulation tests were performed by IV administration of
10 lg/kg TRH.e Blood samples for the determination of plasma
TSH and prolactin concentrations were collected in chilled hep-
arin-coated tubes immediately before and 10 and 20 minutes after
TRH administration.
GH-releasing hormone (GHRH) stimulation tests were per-
formed by IV administration of 1 lg/kg human GHRH.f Blood
samples for determination of plasma GH concentration were col-
lected in chilled EDTA-coated tubes immediately before and
20 minutes after GHRH administration.
The minimal interval between the stimulation tests was 1 day.
After collection, blood samples were immediately centrifuged at
4°C for 10 minutes at 3000 9 g. Plasma was stored at 25°C until
assayed.
Diagnostic imaging
Scintigraphic imaging of the thyroid glands was performed with
the Integrated ORBITER Gamma Camera System with Open Icon
Workstation, equipped with a high-resolution parallel-hole colli-
mator.g The dogs were injected IV with a dose of 80–90 MBq
99mTcO4
. Forty-ﬁve minutes after administration of the radio-
pharmaceutical, planar images of the thyroid glands were made
during 60 seconds (matrix, 256 9 256).16
Computed tomography images of the pituitary gland and
hypothalamus were obtained, both before and after IV administra-
tion of 2 mL/kg of contrast medium,h with a single detector helical
CT uniti by 2-mm-thick transverse slices with a pitch of 1
(120 kV, 180–260 mA). The pituitary height (in mm)/brain area
(in mm2) value was calculated as described previously.17
DNA sequence analysis of TSHB and TRHR
The localization of the exon-intron borders, PCR ampliﬁcation
reactions, PCR programs, DNA sequencing reactions, and meth-
ods of DNA sequence analysis are described in the supporting
information ﬁle.
Results
Between 2008 and 2012, 7 Miniature Schnauzers (3
dwarfs, 4 nondwarfs) were diagnosed with central
hypothyroidism. In ﬁve of these animals the secondary
nature of the hypothyroidism was diagnosed by a 3-day
TSH-stimulation test (2 dwarfs, 3 nondwarfs) and in 2
dogs by a TRH-stimulation test (1 dwarf, 1 nondwarf).
In one of the dwarfs in which the 3-day-TSH stimula-
tion test was performed, only thyroid scintigraphy (and
not plasma TT4 concentration measurement) was
repeated after 3 days. Five dogs were intact males (4
nondwarfs, 1 dwarf) and 2 intact females (2 dwarfs).
Ages ranged from 7 months to 2 years in the dwarfs
and from 5 to 8 years in the nondwarfs. Pedigrees of 3
dwarfs and 3 nondwarfs were available for analyses
(Fig 1). Two dwarfs were full siblings from diﬀerent lit-
ters, and 1 dwarf and 3 nondwarfs had a common
ancestor. The pedigrees display short inbreeding loops
in the ancestry of 2 dwarfs and 4 nondwarfs, suggesting
that a recessive gene variant plays a role in the etiology.
The dogs were referred for various clinical signs that
were already present at a very young age (all dwarfs) or
had been observed for the ﬁrst time 4–8 weeks before
admittance (all nondwarfs). History taking revealed
mental dullness and lethargy in all dogs, superﬁcial pyo-
derma in 2 nondwarfs, mild to moderate obesity in 1
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dwarf and all nondwarfs, and impaired dentition in 2
dwarfs. The dwarf Miniature Schnauzers weighed 4.2–
6 Kg (median 4.8 Kg) and the body weight of the
nondwarfs ranged from 11.4 to 13.8 Kg (median
12.5 Kg). Physical examination of the dwarfs revealed
disproportionate dwarﬁsm (Fig 2) including a short
neck, small head and short legs (n = 3), a scaly skin
(n = 3), weak pulses (n = 1), mandibular prognathism
(n = 2), kyphosis (n = 1), and lordosis (n = 1). Two
dwarfs had hind leg weakness. In the nondwarfs, physi-
cal examination revealed a scaly skin (n = 3), alopecia
between the shoulder blades, on the caudal back and
tail (n = 2), weak pulses (n = 1) and hind leg weakness
(n = 2). The neurological examination was otherwise
unremarkable in all dogs and thyroid palpation was
also unremarkable in all cases.
Complete blood count revealed mild anemia in 1
dwarf and 2 nondwarfs. Complete blood biochemistry
proﬁle was unremarkable in the dwarfs. In the non-
dwarfs, it revealed mild hypoalbuminemia (n = 1),
mildly severely increased plasma alkaline phosphatase
activity (n = 3), mildly increased plasma alanine
transaminase activity (n = 2), moderate to severe hyper-
cholesterolemia, and mild to severe hyperlipidemia
(n = 3).
Hormone measurements and function tests
Two dwarfs and 4 nondwarfs had a plasma TT4 con-
centration <0.16 lg/dL (<2 nmol/L). The remaining
dwarf had a plasma TT4 concentration of 0.93 lg/dL
(12 nmol/L). The plasma TSH concentration was below
the detection limit of the assay in the dwarfs and ran-
ged from 0.04 to 0.17 ng/mL (median, 0.06 ng/mL) in
the nondwarfs.
Repeated administration of rhTSH during 3 consecu-
tive days in 1 dwarf and 3 nondwarfs resulted in a clear
increase in plasma TT4 concentration (Fig 3). TRH was
administered in 3 dwarfs and 3 nondwarfs and did not
result in an increase in plasma TSH concentration
(Fig 4).
Plasma prolactin concentration after TRH adminis-
tration was measured in 1 dwarf and 2 nondwarfs. In
the dwarf, TRH administration failed to result in an
Fig 1. Pedigrees of 6 Miniature Schnauzers with central hypothyroidism. Males are depicted by squares and females by circles. Dogs with
central hypothyroidism are indicated by the black symbols. Dogs 1–3 are dwarfs, and dogs 4–7 are of normal stature. Both pedigrees con-
tain inbreeding loops.
Fig 2. A 4-year-old female intact Miniature Schnauzer dwarf
with central hypothyroidism standing in front of an unaﬀected
dog of the same breed, age, and sex. Note the relatively short neck
and limbs and the relatively small head of the dog.
Fig 3. Eﬀect of IV administration of 90 lg recombinant human
thyroid-stimulating hormone (rhTSH) on 3 consecutive days on
plasma total thyroxine (TT4) concentration. In all dogs, repeated
rhTSH administration resulted in a clear increase in plasma TT4
concentration.
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increase in plasma prolactin concentration (maximal
increase of 0.1 lg/L). In contrast, a clear rise was
observed in the 2 nondwarfs (maximal increase of 10.2
and 13.2 lg/L).18 Prolactin was not measured in the
other dogs.
Basal plasma GH concentration was measured in 2
dwarfs and 2 nondwarfs. It was within reference inter-
val in 1 dwarf (0.8 lg/L) and high (8.9 lg/L) in the
other dwarf. In the 2 nondwarfs, plasma GH concentra-
tion was within the reference range (1.3 and 3.0 lg/L).
Basal plasma IGF-I was measured in 3 dwarfs and 2
nondwarfs and ranged from 19 to 72 lg/L in the dwarfs
and 100–118 lg/L in the nondwarfs.
Administration of GHRH to the 3 dogs (1 dwarf, 2
nondwarfs) with a basal plasma GH concentration
≤3.0 lg/L resulted in a clear rise of this parameter in
the dwarf and in one of the nondwarfs (maximal
increase of 3.4 and 5.6 lg/L). In the other nondwarf,
there was no increase in plasma GH concentration after
stimulation with GHRH. However, the plasma IGF-I
concentration was 100 lg/L in this dog.
Basal plasma ACTH (1 dwarf, 3 nondwarfs) and cor-
tisol (1 dwarf, 1 nondwarf) concentrations were within
reference range in all dogs (median, 27 pg/mL; range,
20–52 pg/mL; 1.1 and 2.1 lg/dL, respectively).
Diagnostic imaging
In all 7 dogs, little to no uptake of 99mTcO4
 by
the thyroid glands was seen (Fig 5a). Repeated admin-
istration of rhTSH during 3 consecutive days (2
dwarfs, 3 nondwarfs) resulted in increased thyroid
uptake of 99mTcO4
 on day 3 (Fig 5b). In 5 dogs (2
dwarfs, 3 nondwarfs), including the 2 dogs in which
the secondary nature of the hypothyroidism was not
proven by a 3-day-TSH-stimulation test, the thyroid
glands could still be identiﬁed on the scintiscan and
had a normal shape (Fig 5a), indicating central
hypothyroidism.
A CT scan of the pituitary area including the
hypothalamus (1 dwarf and 2 nondwarfs) revealed no
Fig 4. Thyrotropin-releasing hormone (TRH)-stimulation test. IV administration of TRH did not lead to an increase in plasma thyroid-
stimulating hormone (TSH) concentration in any of the dogs tested.
A B
Fig 5. Scintigraphic image of the thyroids of a 1-year-and-8-month-old Miniature Schnauzer with central hypothyroidism. (A) Before
stimulation with recombinant human thyroid-stimulating hormone (rhTSH). Note the severely decreased thyroid uptake of radioactive
pertechnetate. The thyroids are of normal shape. (B) After 3 days of IV administration of 90 lg rhTSH. Note the clearly improved uptake
of radioactive pertechnetate by the thyroids.
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abnormalities. The P/B values were within the lower
quarter of the reference range (0.14–0.16 [0.14–0.3117]).
Follow-up
The animals were treated with synthetic levothyrox-
ine,j with a starting dose of 10–20 lg/kg q 12 hour.
After 1–3 months (median 6 weeks), the dogs came for
checkup. All owners reported that their animals became
more active. In the 2 nondwarfs with alopecia, the hair
coat was restored. In all dogs of normal stature, obesity
improved (total weight loss ranged from 300 g to
3.7 Kg [median 2.8 Kg]). The weakness of the hind
limbs also resolved in the 2 dwarfs and 2 nondwarfs.
The plasma TT4 concentration ranged from 2.18 to
5 lg/dL (28–64 nmol/L) in the dwarfs and 1.3–3.5 lg/
dL (14–45 nmol/L) in the nondwarfs.
DNA sequence analysis of TSHB
DNA was collected from 3 dwarfs, 3 nondwarfs, and
25 control Miniature Schnauzers. The DNA sequence
of the 3 exons and the introns of TSHB were analyzed
in these animals. Compared to the reference dog gen-
ome, all cases were homozygous for T instead of A at
position c.-63, which is part of the putative TATA-box.
However, 6 of the 25 control dogs were also homozy-
gous for T at this position and 13 dogs were heterozy-
gous for A/T. In intron 1 at position c.-2 + 371, all
cases were homozygous for C, whereas the reference
dog genome was homozygous for T. Of 5 control dogs,
3 were also homozygous for C and 2 were heterozygous
for C/T. Finally, in intron 1 at position c.-1639, all
cases were homozygous for A, whereas the reference
dog genome was homozygous for G. Of 5 control dogs,
2 were homozygous for A and 3 were heterozygous for
A/G at this position. Otherwise, the sequence of TSHB
of the cases was in agreement with the reference dog
genome.
DNA sequence analysis of TRHR
The DNA sequence of the 2 exons and the intron
boundaries of TRHR were analyzed in 3 dwarfs, 3
nondwarfs, and 6 control dogs. DNA sequence analysis
revealed 2 variations. Three cases, 1 dwarf and 2 non-
dwarfs, were homozygous for A at position c.-73,
whereas the reference dog genome was homozygous for
G. These dogs were also homozygous for C at position
c.-94, whereas the reference dog genome was homozy-
gous for T. One case was heterozygous for both varia-
tions. No other mutations were found.
Discussion
This study demonstrates that central hypothyroidism
could be an underdiagnosed disorder in Miniature
Schnauzers with signs indicative of deﬁcient thyroid
hormone secretion. Whereas primary hypothyroidism is
commonly diagnosed in dogs, central hypothyroidism is
rarely reported.7–11 The fact that this rare disorder
occurred in 7 dogs from the same breed suggests that
central hypothyroidism could have a genetic back-
ground in Miniature Schnauzers. However, no disease-
causing mutations were found in the TSHB gene and
exons of the TRHR gene.
Diﬀerentiating primary and central hypothyroidism is
problematic because TSH deﬁciency in central hypothy-
roidism results in atrophy of the thyroid gland, with
resultant inadequate thyroxine secretion or radionuclide
uptake on TSH stimulation testing and nuclear scintig-
raphy, respectively.19–21 The relatively low sensitivity of
increased plasma TSH concentration in dogs with pri-
mary hypothyroidism contributes to the diﬃculty in the
diagnosis of central hypothyroidism. The situation in
Miniature Schnauzers opens the possibility that sec-
ondary hypothyroidism is more common than thought
in other breeds as well and may in part explain the low
sensitivity of the canine TSH assay.
Absence of an increase in plasma TSH concentration
after TRH administration is not fully diagnostic for
central hypothyroidism. Also in dogs with primary
hypothyroidism, TRH administration does not result in
a signiﬁcant rise in plasma TSH concentration.19–21 In 5
of the dogs, the central nature of the hypothyroidism
was conﬁrmed by administering rhTSH on 3 consecu-
tive days.1 Cases of long-standing central hypothy-
roidism with subsequent thyroid atrophy often fail to
respond to a single dose of TSH.22 Repeated adminis-
tration of TSH will result in the reactivation of thyroid
tissue, which will not occur in primary hypothyroidism.9
The reactivation of thyroid tissue was shown by an
increase in circulating TT4 concentration (4 dogs) and
thyroid uptake of 99mTcO4
 (5 dogs). In the remaining
2 dogs, the diagnosis of central hypothyroidism was
based on scintigraphy. In these dogs, the thyroid glands
could still be identiﬁed and had a normal shape. In con-
trast, in dogs with primary hypothyroidism, immune-
mediated destruction will result in no or a very irregular
uptake of 99mTcO4
.
Central hypothyroidism may be because of either iso-
lated TSH deﬁciency or combined pituitary hormone
deﬁciency. To determine whether a dog also has a deﬁ-
ciency of GH, ACTH, prolactin, or gonadotropins, the
pituitary can be stimulated with GHRH, corticotropin-
releasing hormone (CRH), TRH, and gonadotropin-
releasing hormone (GnRH).
In the previous reports about congenital central
hypothyroidism in dogs, GH response to provocative
testing was blunted.9,10 Because these dogs did not show
signs of GH deﬁciency, the authors suggested that this
suboptimal response was not because of a defect of the
somatotropic cells. In the present report, 2 of the 3
Miniature Schnauzers in which a GHRH-stimulation
test was performed, responded to GHRH administra-
tion with a normal increase in plasma GH concentra-
tion, indicating that the somatotropic cells were
unaﬀected. Interestingly, one of the Miniature
Schnauzers did not respond with a rise in plasma GH
concentration after GHRH administration. In contrast
to the other 2 Miniature Schnauzers, this dog was
already treated with levothyroxine at the time of the
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GHRH-stimulation test. The absence of a rise in plasma
GH concentration after GHRH administration may be
explained by the feedback eﬀect of the exogenous thy-
roid hormones at the hypothalamic level, resulting in an
increased somatostatin tone,20 which will suppress both
the basal GH secretion and the eﬀect of provocative
testing. This, combined with the fact that this Miniature
Schnauzer did not display growth retardation and had
a plasma IGF-I concentration of 100 lg/L, makes GH
deﬁciency unlikely in this animal.
In the dwarf Giant Schnauzers,9 ACTH response to
CRH was reported as normal. In these Miniature
Schnauzers, no CRH-stimulation test was performed.
However, basal plasma concentrations of ACTH and
cortisol were determined in 4 (1 dwarf, 3 nondwarfs)
and 2 (1 dwarfs, 1 nondwarf) dogs, respectively, and
were within their respective reference ranges.15 These
ﬁndings suggest normal corticotropic function. Never-
theless, a CRH-stimulation test would be required in all
cases for optimal evaluation of the hormone secreting
capacity of the corticotropic cells.
Although all dogs had central hypothyroidism, there
seemed to be at least 2 diﬀerent subclasses. Three dogs
displayed disproportionate dwarﬁsm, a hallmark of con-
genital hypothyroidism, whereas the other dogs were of
normal stature. Also the age of disease onset diﬀered
between these 2 groups. This, however, does not neces-
sarily exclude congenital central hypothyroidism in the
dogs of normal stature. It may be that the TSH deﬁ-
ciency in these dogs was mild compared with the dwarf
group, which allowed normal growth. However, it is
also possible that the dwarfs and nondwarfs suﬀer from
a diﬀerent form of hypothyroidism.
The TRH-stimulation test failed to result in an
increase in plasma prolactin concentration in one of the
dwarf Miniature Schnauzers, but resulted in a clear rise
of this hormone in the 2 dogs of normal size. This
could also suggest that these animals are aﬀected by 2
diﬀerent disorders and that dwarf Miniature Schnauzers
could have a combined deﬁciency of TSH and pro-
lactin. It is however not possible to draw ﬁrm conclu-
sions on the results of TRH response testing in just 3
dogs.
The dogs had no history of head trauma that could
explain low TSH secretion. To evaluate if there was
any indication that the central hypothyroidism was
acquired in another way, CT scanning of the pituitary
area was performed. Instead of being increased, as
can be expected in acquired forms of central hypothy-
roidism such as lymphocytic adenohypophysitis3 or a
pituitary tumor, the P/B value was in the low end of
the reference range in both the dwarfs and the non-
dwarfs, making congenital maldevelopment of the
pituitary a more feasible option in both groups. Also
the fact that this rare disorder occurred in 7 dogs
from the same breed suggests that central hypothy-
roidism may have a genetic background in Miniature
Schnauzers.
If central hypothyroidism in Miniature Schnauzers
were to have a genetic background, TSHB would serve
as a prime candidate gene.23,24 All tested case dogs were
homozygous for T instead of A at c.-64. This A to T
mutation aﬀects the putative TATA-box. The TATA-
box is an important element in many gene promoters of
vertebrates and the functionality of the homologous
TATA-box in tshb of the mouse has been demon-
strated.25 However, 6 out of 25 control Miniature
Schnauzers were homozygous for T at c.-64 as well. If
this mutation would be responsible for central hypothy-
roidism, it would have a very low penetrance. We can-
not rule out the possibility that the eﬀect of this
mutation on TSHB expression is enhanced by another
genetic or environmental factor in the patients. The
other 2 variations that were found in intron 1 of TSHB
at position c.-2 + 371 and at position c.-1639 were
regarded as single nucleotide polymorphisms (SNPs),
because the cases and a number of control dogs were
homozygous for these variants.
A candidate gene that could explain both TSH and
prolactin deﬁciency is TRHR,26 because TRH stimulates
both the thyrotropes and the lactotropes. The variations
found in the noncoding region of exon one of TRHR
could be related to the promoter region of this gene
and therefore to the expression of the protein. However,
the corresponding haplotype was only found in 3 of 6
cases, of which 2 belonged to the dwarf and 1 to the
nondwarf group (without prolactin deﬁciency) and
therefore regarded as insigniﬁcant.
Because of its retrospective nature, this study has
some limitations. Because not all pituitary hormone
stimulation tests were performed, it is not clear if an
isolated or combined form of TSH deﬁciency is present
in these Miniature Schnauzers and if the dogs have the
same or diﬀerent forms of central hypothyroidism. Fur-
ther studies to determine the secretory capacity of all
adenohypophyseal hormones are needed to determine
the underlying cause(s) of the central hypothyroidism in
this breed.
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